Global and China Gastrointestinal Therapeutics and Diagnostics Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.

    This report elaborates on the current development of the Gastrointestinal Therapeutics and Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AstraZeneca

    • Salix Pharmaceuticals

    • Johnson & Johnson

    • Abbott Laboratories

    • Takeda Pharmaceutical Company

    • Eisai Co, Ltd

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Diagnostics

    • Therapeutics

    Application:

    • Gastroenteritis

    • GI Bleeding

    • Irritable Bowel Syndrome

    • Peptic Ulcer Disease (PUD)

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Gastrointestinal Therapeutics and Diagnostics Industry Overview

      • 1.1.1 Gastrointestinal Therapeutics and Diagnostics Market Scope and Market Segments

      • 1.1.2 Gastrointestinal Therapeutics and Diagnostics Industry Characteristics

      • 1.1.3 Global and China Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Gastrointestinal Therapeutics and Diagnostics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Diagnostics

      • 1.2.2 Therapeutics

    • 1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Gastroenteritis

      • 1.3.2 GI Bleeding

      • 1.3.3 Irritable Bowel Syndrome

      • 1.3.4 Peptic Ulcer Disease (PUD)

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Gastrointestinal Therapeutics and Diagnostics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Gastrointestinal Therapeutics and Diagnostics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Gastrointestinal Therapeutics and Diagnostics Industry PEST Analysis

    • 2.3 Gastrointestinal Therapeutics and Diagnostics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Gastrointestinal Therapeutics and Diagnostics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Gastrointestinal Therapeutics and Diagnostics Industry

    Chapter 3 Global and China Gastrointestinal Therapeutics and Diagnostics Market, by Manufacturer

    • 3.1 Global and China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Gastrointestinal Therapeutics and Diagnostics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Gastrointestinal Therapeutics and Diagnostics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Gastrointestinal Therapeutics and Diagnostics Market Top 3 Players

    Chapter 4 Global and China Gastrointestinal Therapeutics and Diagnostics Market, by Type (2017-2028)

    • 4.1 Gastrointestinal Therapeutics and Diagnostics Market Trend, by Type

    • 4.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Gastrointestinal Therapeutics and Diagnostics Price Trend, by Type (2017-2028)

    • 4.3 China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Gastrointestinal Therapeutics and Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Gastrointestinal Therapeutics and Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Gastrointestinal Therapeutics and Diagnostics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Gastrointestinal Therapeutics and Diagnostics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Gastrointestinal Therapeutics and Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Gastrointestinal Therapeutics and Diagnostics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Gastrointestinal Therapeutics and Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Gastrointestinal Therapeutics and Diagnostics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Gastrointestinal Therapeutics and Diagnostics Market Analysis

    • 7.1 North America Gastrointestinal Therapeutics and Diagnostics Market, by Type

    • 7.2 North America Gastrointestinal Therapeutics and Diagnostics Market, by Application

    • 7.3 North America Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast, by Country

      • 7.3.1 United States Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Gastrointestinal Therapeutics and Diagnostics Market Analysis

    • 8.1 Europe Gastrointestinal Therapeutics and Diagnostics Market, by Type

    • 8.2 Europe Gastrointestinal Therapeutics and Diagnostics Market, by Application

    • 8.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Gastrointestinal Therapeutics and Diagnostics Market Analysis

    • 9.1 APAC Gastrointestinal Therapeutics and Diagnostics Market, by Type

    • 9.2 APAC Gastrointestinal Therapeutics and Diagnostics Market, by Application

    • 9.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast, by Country

      • 9.3.1 China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Analysis

    • 10.1 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market, by Type

    • 10.2 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market, by Application

    • 10.3 Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Gastrointestinal Therapeutics and Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Gastrointestinal Therapeutics and Diagnostics Company Profiles

      • 11.1 AstraZeneca

        • 11.1.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.1.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Salix Pharmaceuticals

        • 11.2.1 Salix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.2.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Johnson & Johnson

        • 11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.3.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Abbott Laboratories

        • 11.4.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.4.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Takeda Pharmaceutical Company

        • 11.5.1 Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.5.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Eisai Co, Ltd

        • 11.6.1 Eisai Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Product Profiles, Application and Specification

        • 11.6.3 Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Gastrointestinal Therapeutics and Diagnostics Industry Investment Prospect and Risk Assessment

    • 12.1 Gastrointestinal Therapeutics and Diagnostics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Gastrointestinal Therapeutics and Diagnostics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Therapeutics (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Gastroenteritis (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of GI Bleeding (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Irritable Bowel Syndrome (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Peptic Ulcer Disease (PUD) (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Therapeutics and Diagnostics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Therapeutics and Diagnostics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Gastrointestinal Therapeutics and Diagnostics Market Share, by Manufacturer in 2021

    • Figure Global and China Gastrointestinal Therapeutics and Diagnostics Market Share, by Manufacturer in 2022

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Type (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Price Trend, by Type (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Value, by Type (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Price Trend, by Type (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Value, by Application (2017-2028)

    • Table Global Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Application (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Value, by Application (2017-2028)

    • Table China Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Table North America Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table North America Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure North America Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table North America Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table North America Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure North America Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure United States Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Therapeutics and Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Therapeutics and Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eisai Co, Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eisai Co, Ltd Product Profiles, Application and Specification

    • Table Eisai Co, Ltd Gastrointestinal Therapeutics and Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.